ASCO 2026 Update – Advanced Ovarian Cancer
This Medudy course is a video podcast for physicians on the topic of “Primary vs. Interval Surgery in Advanced Ovarian Cancer.” Prof. Dr. Sven Mahner and Prof. Dr. Fabian Trillsch discuss the role of surgical therapy in advanced ovarian cancer on the sidelines of the American cancer conference ASCO 2026. The focus is on recent analyses of the TRUST study comparing primary […]
Long-Term Management and Adverse Effect Management with Lorlatinib – Weight Gain
This Medudy course is a video tutorial for physicians on the topic of “Long-Term Management and Side Effect Management with Lorlatinib—Weight Gain.” In this video, Dr. Carolin Groß-Ophoff, senior physician in hematology and oncology at the City of Cologne Hospitals, discusses the ALK tyrosine kinase inhibitor lorlatinib, which is approved for the treatment of advanced, ALK-positive non-small cell lung cancer. Due to its […]
Long-Term Management and Adverse Effect Management with Lorlatinib – CNS Effects
This Medudy course is a video tutorial for physicians on the topic of “Long-Term Management and Side Effect Management with Lorlatinib—CNS Effects.” In this video, Dr. Carolin Groß-Ophoff, senior physician in hematology and oncology at the City of Cologne Hospitals, discusses the ALK tyrosine kinase inhibitor lorlatinib, which is approved for the treatment of advanced, ALK-positive non-small cell lung cancer. Due to its […]
PTEN Deficiency in Metastatic Hormone-Sensitive Prostate Cancer: Clinical Relevance and Unmet Medical Needs
This Medudy course is a video tutorial for physicians on the topic “PTEN Deficiency in Metastatic Hormone-Sensitive Prostate Cancer: Clinical Relevance and Unmet Medical Needs.” In this video, Prof. Markus Eckstein of the Institute of Pathology at Erlangen University Hospital discusses the clinical significance of PTEN alterations in metastatic hormone-sensitive prostate cancer (mHSPC). The loss of the tumor suppressor PTEN activates […]
mCRPC – metastatic castration-resistant prostate cancer
This Medudy Master Class Series is a video tutorial for physicians on prostate cancer. This four-part module focuses on metastatic castration-resistant prostate cancer (mCRPC) and is presented by Prof. Dr. Martin Bögemann, senior physician in urology and pediatric urology at the University Hospital in Münster. The first part deals with first-line therapy for mCRPC, taking into account the […]
Darolutamide + ADT for Metastatic Hormone-Sensitive Prostate Cancer: ARASEC
This Medudy course is a video tutorial for physicians on the topic of “Darolutamide + ADT for Metastatic Hormone-Sensitive Prostate Cancer (ARASEC).” The format used here is a “Journal Club Summary,” in which we summarize the latest and most clinically relevant studies for you. In metastatic hormone-sensitive prostate cancer (mHSPC), the combination of an androgen receptor pathway inhibitor (ARPI) […]
Olaparib: Developments and Prospects for PARP Inhibition in Cancer Therapy
This Medudy series is a video tutorial for physicians on “Olaparib: Developments and Prospects for PARP Inhibition in Cancer Therapy.” This four-part module examines the use of olaparib in various oncological indications and is presented by an interdisciplinary team of experts. To begin, Professor Peter Hammerer discusses combination therapy with olaparib and abiraterone […]
Treatment of Metastatic Cervical Cancer
This Medudy course is a video tutorial for physicians on the topic “Treatment of Metastatic Cervical Cancer: Tisotumab Vedotin and the KEYNOTE-826 Trial.” The format used here is a “Journal Club Summary,” in which we summarize the latest and most clinically relevant studies for you. For patients with recurrent or metastatic cervical cancer, treatment options after […]
Treatment of Locally Advanced Cervical Cancer (KEYNOTE-A18 Trial)
This Medudy course is a video tutorial for physicians on the topic “KEYNOTE-A18: Pembrolizumab Plus Radiochemotherapy for Locally Advanced Cervical Cancer.” The format used here is a “Journal Club Summary,” in which we summarize the latest and most clinically relevant studies for you. Patients with locally advanced cervical cancer continue to have a significant […] despite combined chemoradiotherapy.
mCRPC – metastatic castration-resistant prostate cancer
This Medudy Master Class Series is a video tutorial for physicians on prostate cancer. This four-part module focuses on metastatic castration-resistant prostate cancer (mCRPC) and is presented by Prof. Dr. Martin Bögemann, senior physician in urology and pediatric urology at the University Hospital in Münster. The first part deals with first-line therapy for mCRPC, taking into account the […]